Notch2 signaling is required for potent antitumor immunity in vivo.
Sugimoto K, Maekawa Y, Kitamura A, Nishida J, Koyanagi A, Yagita H, Kojima H, Chiba S, Shimada M, Yasutomo K.
Sugimoto K, et al. Among authors: kojima h.
J Immunol. 2010 May 1;184(9):4673-8. doi: 10.4049/jimmunol.0903661. Epub 2010 Mar 29.
J Immunol. 2010.
PMID: 20351182